MD Anderson Research Highlights for December 13, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research...
ASH: Mantle cell lymphoma patients see improved outcomes...
ABSTRACT: LBA-2
The targeted therapy combination of ibrutinib and venetoclax significantly improved progression-free survival (PFS)...
ASH: Novel combination therapy significantly reduces spleen...
ABSTRACT: 620
Combining the JAK inhibitor ruxolitinib with the BCL-xL inhibitor navitoclax was twice as effective in reducing...
ASH: Targeted oral therapy reduced disease burden and improved...
ABSTRACT: 77
The targeted therapy bezuclastinib was safe and rapidly reduced markers of disease burden while also improving symptoms...
ASH: Novel menin inhibitors show promise for patients with...
ABSTRACTS: 57, 58
Two clinical trials led by researchers from The University of Texas MD Anderson Cancer Center demonstrated...
SABCS: Combining ribociclib with hormone therapy improved...
ABSTRACT: GA03-03
Targeted treatment with ribociclib plus hormone therapy provided significant invasive disease-free survival (iDFS...
MD Anderson and Rigel Pharmaceuticals announce strategic...
The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development...
SABCS: Studies suggest novel targeted therapies may benefit...
ABSTRACTS: RF01-04 and RF01-07
Two studies led by researchers at The University of Texas MD Anderson Cancer Center demonstrated...
MD Anderson Research Highlights: ASH 2023 Special Edition
ABSTRACTS: 162, 309, 322, 364, 741, 774, 856, 983
SAN DIEGO ― The University of Texas MD Anderson Cancer Center’s Research...
MD Anderson, TACC and the Oden Institute announce funding for the...
The University of Texas MD Anderson Cancer Center, the Oden Institute for Computational Engineering and Sciences and the Texas...
MD Anderson’s Katy Rezvani, M.D., receives 2023 Honorific...
Katy Rezvani, M.D., Ph.D., professor of Stem Cell Transplantation & Cellular Therapy at The University of Texas MD Anderson...